Financhill
Back

Novartis AG 10K Form

Buy
64

NVS
Novartis AG

Last Price:
96.74
Seasonality Move:
3.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVS News And Ratings

See the #1 stock for the next 7 days that we like better than NVS

NVS Financial Statistics

Sales & Book Value

Annual Sales: $46.66B
Cash Flow: $1.76B
Price / Cash Flow: 17.28
Annual Sales: $22.83
Price / Book: 4.24

Profitability

EPS (TTM): 7.10000
Net Income (TTM): $14.85B
Gross Margin: $34.19B
Return on Equity: 29.93%
Return on Assets: 13.42%

Novartis AG Earnings Forecast

Key Novartis AG Financial Ratios

  • The Gross Profit Margin over the past 26 years for NVS is 73.27%.
  • The Selling, General & Administrative Expenses for NVS have been equal to 26.83% of Gross Profit Margin.
  • The Research & Development expenses have been 24.37% of Revenue.
  • The Interest Expense is 5.76% of Operating Income.
  • The Net Earning history of NVS is 31.83% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 17 years.

Novartis AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Drug Manufacturers - General
Sector: Healthcare
Current Symbol: NVS
CUSIP: 66987V
Website: novartis.com

Debt

Debt-to-Equity Ratio: 0.53
Current Ratio: 1.16
Quick Ratio: 0.88

Price-to-Earnings

Trailing P/E Ratio: 13.62
Forward P/E Ratio: 12.54

NVS Technical Analysis vs Fundamental Analysis

Buy
64
Novartis AG (NVS) is a Buy

Is Novartis AG a Buy or a Sell?

  • Novartis AG stock is rated a Buy
    The current Novartis AG [NVS] share price is $96.73. The Score for NVS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.